PATENT CLAIM ANALYSIS

Application Number: 16252931
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "432000"]

Abstract:
A method, medicated feminine sanitary products and pharmaceutical compositions for reducing menstrual blood loss in a female are provided. The method includes administering a hemostatic agent on a medicated feminine sanitary product during menstrual bleeding, wherein the hemostatic agent is incorporated in the medicated feminine sanitary product as a pharmaceutically acceptable composition, wherein the hemostatic agent is ε-amino-caproic acid, wherein the feminine sanitary product includes an amount of ε-amino-caproic acid ranging from 100 mg to 500 mg.

Claim (Index 17):
The pharmaceutical composition of  claim 14 , wherein the pharmaceutical composition is formulated as a tablet.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.69388
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13016800', '12714181', '12433510', '13230902', '11455855']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7383259760634515
- 35 USC 102 Novelty (BERT): 0.5049733654498839
- Combined Prediction Score: 0.7149907150020949
- Mean Citation Score: 256.04021800000004
- Max Citation Score: 278.6265
- Similarity Product: 217.59760280746224

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test